Jupiter Topco LLC bought a new position in Ingredion Incorporated (NYSE:INGR – Free Report) in the 2nd quarter, Holdings Channel reports. The firm bought 26,662 shares of the company’s stock, valued at approximately $2,526,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Hsbc Holdings PLC purchased a new position in shares of Ingredion during the second quarter valued at $1,355,000. Legal & General Group Plc purchased a new stake in Ingredion in the second quarter worth about $8,290,000. The Manufacturers Life Insurance Company purchased a new stake in Ingredion in the second quarter worth about $4,260,000. Cibc World Market Inc. bought a new position in Ingredion during the 2nd quarter worth about $5,775,000. Finally, Sanctuary Advisors LLC bought a new position in Ingredion during the 2nd quarter worth about $1,884,000. Institutional investors own 85.27% of the company’s stock.
Wall Street Analysts Forecast Growth
INGR has been the topic of a number of research reports. Barclays cut their target price on shares of Ingredion from $120.00 to $118.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 5th. Weiss Ratings downgraded shares of Ingredion from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, July 8th. Benchmark reissued a “buy” rating on shares of Ingredion in a report on Tuesday, June 9th. Oppenheimer downgraded shares of Ingredion from an “outperform” rating to a “market perform” rating in a research note on Monday, June 8th. Finally, UBS Group upped their target price on Ingredion from $104.00 to $108.00 and gave the stock a “neutral” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $121.29.
Insider Activity at Ingredion
In related news, Director David B. Fischer sold 1,662 shares of the business’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $102.31, for a total transaction of $170,039.22. Following the completion of the transaction, the director owned 19,930 shares in the company, valued at $2,039,038.30. The trade was a 7.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.
Ingredion Price Performance
INGR opened at $102.66 on Thursday. The business’s 50-day moving average is $101.71 and its two-hundred day moving average is $106.41. Ingredion Incorporated has a 1 year low of $94.44 and a 1 year high of $128.98. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.80 and a quick ratio of 1.92. The firm has a market capitalization of $6.47 billion, a PE ratio of 11.20, a price-to-earnings-growth ratio of 0.89 and a beta of 0.62.
Ingredion (NYSE:INGR – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $2.82 EPS for the quarter, topping analysts’ consensus estimates of $2.71 by $0.11. The business had revenue of $1.85 billion during the quarter, compared to the consensus estimate of $1.83 billion. Ingredion had a net margin of 8.21% and a return on equity of 15.40%. The firm’s revenue was up .9% on a year-over-year basis. During the same period in the previous year, the company posted $2.87 earnings per share. Ingredion has set its FY 2026 guidance at 10.300-10.900 EPS. Research analysts anticipate that Ingredion Incorporated will post 10.6 earnings per share for the current fiscal year.
Ingredion Profile
Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.
The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.
Further Reading
- Five stocks we like better than Ingredion
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding INGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingredion Incorporated (NYSE:INGR – Free Report).
Receive News & Ratings for Ingredion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion and related companies with MarketBeat.com's FREE daily email newsletter.
